Clinical Trial Update: Trial to Investigate GZ21T in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GZ21T in healthy volunteers has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• GZ21T

Snippet

Sponsor: Genzada Pharmaceuticals USA, Inc. | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED | Results posted: 2026-01-28